US equities
|
INTC
$64.61
▼-29.82%
AMZN
$238.97
▼-1.98%
MU
$881.25
▼-5.68%
NVDA
$204.49
▼-4.29%
SNDK
$1,165.98
▼-12.34%
GOOGL
$280.79
▼-1.07%
AMD
$503.56
▼-11.10%
SPCX
$137.97
▼-4.11%
INTC
$64.61
▼-29.82%
AMZN
$238.97
▼-1.98%
MU
$881.25
▼-5.68%
NVDA
$204.49
▼-4.29%
SNDK
$1,165.98
▼-12.34%
GOOGL
$280.79
▼-1.07%
AMD
$503.56
▼-11.10%
SPCX
$137.97
▼-4.11%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about XCNQ:MBIO
Recent news which mentions XCNQ:MBIO
Mindbio Announces Intention To Refile MD & A
February 14, 2025
Tickers
MBIO
Tags
XCNQ:MBIO
#Medical
#Healthcare
From
TheNewswire.com - RSS (Media)
Mindbio Announces Clinical Trial Milestone In Phase 2B Microdosing Trials Targeting Existential Distress, Depression & Anxiety In Advanced Stage Cancer
October 24, 2024
Tickers
MBIO
Tags
#Healthcare
XCNQ:MBIO
#Medical
From
TheNewswire.com - RSS (Media)